MCK

$885.84-13.11 (-1.46%)

Market ClosedAs of Mar 20, 8:00 PM UTC

McKesson Corporation provides healthcare services in the United States and internationally.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$885.84
Potential Downside
220.3%
Whystock Fair Value$-1065.25
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Distribution

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Phar...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$109.34B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
25.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.35
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-243.76%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.48

Recent News

Zacks
Mar 20, 2026

Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term outlook.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 20, 2026

Here's Why You Should Add McKesson Stock to Your Portfolio Now

McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 18, 2026

The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies

GE, SHEL and MCK lead Zacks picks, driven by strong demand, cash flow growth and strategic expansion despite cost and market risks.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 18, 2026

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

Top Stock Reports for GE Aerospace, Shell & McKesson

GE Aerospace gains on strong engine demand and defense tailwinds, while Shell and McKesson navigate mixed performance and strategic shifts.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.